Introduction to the Special Section: COVID-19 - insights on pharmacology and pharmacotherapy
Pharmacol Rep
.
2020 Dec;72(6):1445.
doi: 10.1007/s43440-020-00191-2.
Author
Marek Sanak
1
Affiliation
1
Division of Molecular Biology and Clinical Genetics, Department of Medicine, Jagiellonian University Medical College, Skawińska 8, 31-066, Kraków, Poland. nfsanak@cyf-kr.edu.pl.
PMID:
33206322
PMCID:
PMC7672414
DOI:
10.1007/s43440-020-00191-2
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Antiviral Agents / pharmacology*
Antiviral Agents / therapeutic use*
COVID-19 / virology*
COVID-19 Drug Treatment*
Humans
Pandemics
SARS-CoV-2 / drug effects*
Substances
Antiviral Agents